Results 81 to 90 of about 53,147 (119)

Combination interleukin-23p19 inhibitor and Janus kinase inhibitor rescue for steroid-refractory acute severe ulcerative colitis in pregnancy complicated by primary sclerosing cholangitis. [PDF]

Gastroenterol Rep (Oxf)
Quraishi MN, Omar N, Taha H, AlShamshi S, Fadda M, Koutoubi Z.   +5 more
europepmc   +1 more source

Refractory Segmental Hyaline Vasculitis Treated with Janus Kinase Inhibitor Tofacitinib: A Case Report. [PDF]

Clin Cosmet Investig Dermatol
Zhang Y, Xia R.
europepmc   +1 more source

Janus kinase inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism? [PDF]

Res Pract Thromb Haemost
Dawudi Y, Benarroch S, Helfer H, Smadja DM, Mahé I.   +4 more
europepmc   +1 more source

Topical JAK (Janus Kinase) Inhibitor Therapy for Chronic External Otitis in Atopic Dermatitis: A Case Report. [PDF]

Cureus
Hirano K, Hirano Y, Yu M, Tei Y, Shimane T.   +4 more
europepmc   +1 more source

Acute graft versus host disease postliver transplant with mucocutaneous manifestations and pancytopenia: Remission with Janus kinase inhibitor. [PDF]

JAAD Case Rep
Mendoza R, Liu L, Sam A, Abdel-Azim H, Greas M, Dao H.   +5 more
europepmc   +1 more source

Corrigendum to 'Combination of Janus kinase inhibitor and biologic for recalcitrant severe atopic dermatitis'. [PDF]

J Eur Acad Dermatol Venereol
europepmc   +1 more source

Direct Effects of the Janus Kinase Inhibitor Baricitinib on Sensory Neurons. [PDF]

Int J Mol Sci
Vazquez E, Richter F, Natura G, König C, Eitner A, Schaible HG.   +5 more
europepmc   +1 more source

Aggressive cutaneous squamous cell carcinoma in a patient on Janus-kinase inhibitor therapy. [PDF]

JAAD Case Rep
Aragon Sierra AM, Donohoe KJ, Canaday DJ, Gomez ED, Jalisi SM, Koomey MM, Aviles VM, Yu KK.   +7 more
europepmc   +1 more source

Bone Mineral Density During Treatment with The Janus Kinase Inhibitor Baricitinib in Patients with Rheumatoid Arthritis: A Monocentric Observational Study. [PDF]

Calcif Tissue Int
Schulz N, Asendorf T, van Wijnen P, Wilhelmi T, Müller-Ladner U, Lange U, Klemm P.   +6 more
europepmc   +1 more source

Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients-Results From an Australian Expert Consensus Exercise. [PDF]

Australas J Dermatol
Thomas M, Hankins M, Darchini-Maragheh E, Bokhari L, Eisman S, Yip L, York K, Li J, Sharma P, Triwongwaranat D, Chitreddy V, Ghiya R, Kushnir-Grinbaum D, Frewen J, Yong SS, Rathnayake D, Cranwell W, Wall D, Varathan V, Khosrotehrani K, Orchard D, Moussa A, Paranjape M, Sinclair R.   +23 more
europepmc   +1 more source